Shares of Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) fell 10.8% during mid-day trading on Friday . The company traded as low as $1.07 and last traded at $1.07. Approximately 410 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 2,685 shares. The stock had previously closed at $1.20.
Ascletis Pharma Stock Down 10.8%
The company has a fifty day moving average of $1.40 and a 200 day moving average of $1.77.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
See Also
- Five stocks we like better than Ascletis Pharma
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
